Effectiveness of Lumbar Fusion When NanOss Bioactive Is Used With Posterolateral Gutter Fusions

NATerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Degenerative Disc DiseaseSpinal StenosisSpondylolisthesis
Interventions
DEVICE

nanOss Bioactive Bone void filler

Instrumented posterolateral gutter fusions using nanOss Bioactive bone void filler

DEVICE

Interbody FCage

Lumbar fusion using interbody cages with autograft. This will be done in conjunction with the posterolatreal gutter fusion

Trial Locations (7)

29425

Medical University of South Carolina Neurology, Charleston

49855

Advanced Center for Orthopedics, Marquette

53211

Milwaukee Spinal Specialists, Milwaukee

60611

Northwestern Medical Facility, Chicago

65804

St. Johns Spine and Pain Clinic, Springfield

90048

Tower Orthopaedics & Neurosurgical Spine Institute, Beverly Hills

92037

Scripps Memorial Hospital Neurosurgery, La Jolla

All Listed Sponsors
lead

Pioneer Surgical Technology, Inc.

INDUSTRY

NCT01452516 - Effectiveness of Lumbar Fusion When NanOss Bioactive Is Used With Posterolateral Gutter Fusions | Biotech Hunter | Biotech Hunter